AI Resets Healthcare Software: Why Health SaaS Repricing Is a Call to Transact, Not a Verdict

Healthcare software has lost roughly $100 billion of equity value in twelve months, and it has lost it while beating earnings. That is not a judgment on execution. It is the market repricing the terminal value of a delivery model – the one-size-fits-all package, lightly configured, priced by the seat – at the precise moment agentic AI makes institution-specific software economical for the first time. The value released by that shift is larger than the value destroyed. Capturing this value will require transactions and overcoming the cognitive biases of both buyers and sellers that routinely derail life sciences M&A, now intensified by the unprecedented transformation, growth and hype of Health AI.